MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
28.91
-1.64 (-5.37%)
Mar 9, 2026, 1:05 PM EDT - Market open
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $1.36 billion as of March 9, 2026. Its market cap has increased by 244.83% in one year.
Market Cap
1.36B
Enterprise Value
1.04B
1-Year Change
244.83%
Ranking
Category
Stock Price
$28.91
Market Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has increased from $509.66M to $1.36B, an increase of 167.47%. That is a compound annual growth rate of 94.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.44B | 1.72% |
| Dec 31, 2025 | 1.42B | 129.95% |
| Dec 31, 2024 | 615.88M | 20.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nurix Therapeutics | 1.55B |
| Kodiak Sciences | 1.54B |
| Vir Biotechnology | 1.53B |
| Ardelyx | 1.52B |
| Biohaven | 1.49B |
| Capricor Therapeutics | 1.44B |
| Rapport Therapeutics | 1.44B |
| Generate Biomedicines | 1.43B |